Alps Advisors Inc Marker Therapeutics, Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$0.95 - $1.72 $96,739 - $175,149	-101,831 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $12,613 - $21,623	-7,508 Reduced 6.87%	101,831 $172,000
Q2 2021 Aug 11, 2021	BUY	$1.88 - $3.56 $205,557 - $389,246	109,339 New	109,339 $305,000
Q4 2019 Feb 07, 2020	SELL	$2.68 - $4.85 $244,035 - $441,631	-91,058 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$4.1 - $9.0 $16,777 - $36,828	-4,092 Reduced 4.3%	91,058 $465,000
Q2 2019 Aug 07, 2019	BUY	$5.15 - $7.92 $490,022 - $753,588	95,150 New	95,150 $754,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.